Skip to content
CUSTOMER SUPPORT
  • Products
    • CAC™ – Coronary Artery Calcification
    • CT LVAS™ – Lung Ventilation Analysis
    • IQ-UIP™ – Early IPF Detection
    • LDAf™ -Functional Lung Density Analysis
    • LFAi™ – Lung Density Analysis – Inspiration
    • LTA™ – Lung Texture Analysis
    • PHA™ – Pulmonary Hypertension Assessment
    • XV LVAS® – Lung Ventilation Analysis
    • XV Scanner™ – Dedicated Lung Function Scanner
  • Clinical Research
    • Clinical Studies
    • Publications
  • About
    • About Us
    • Our Team
    • ATS
    • Careers
    • Veteran Advocacy
  • Investor Relations
    • Company Information
    • Corporate Governance
    • Results + Reports
    • Share Price and Tools
    • Investor Services
    • Investor Contacts
  • News
    • Latest News
    • Conferences + Events
    • Releases and Archives
    • Blog
  • Contact
    • Contact Us
    • Scan Locations
  • Scan Locations
  • Products
    • CAC™ – Coronary Artery Calcification
    • CT LVAS™ – Lung Ventilation Analysis
    • IQ-UIP™ – Early IPF Detection
    • LDAf™ -Functional Lung Density Analysis
    • LFAi™ – Lung Density Analysis – Inspiration
    • LTA™ – Lung Texture Analysis
    • PHA™ – Pulmonary Hypertension Assessment
    • XV LVAS® – Lung Ventilation Analysis
    • XV Scanner™ – Dedicated Lung Function Scanner
  • Clinical Research
    • Clinical Studies
    • Publications
  • About
    • About Us
    • Our Team
    • ATS
    • Careers
    • Veteran Advocacy
  • Investor Relations
    • Company Information
    • Corporate Governance
    • Results + Reports
    • Share Price and Tools
    • Investor Services
    • Investor Contacts
  • News
    • Latest News
    • Conferences + Events
    • Releases and Archives
    • Blog
  • Contact
    • Contact Us
    • Scan Locations
  • Scan Locations

Year: 2023

Quarterly Activity Report and Appendix 4C for Q1 FY2024

FY2023 Full Year Results

Annual Report and Appendix 4E

2023 Annual Report

Quarterly Activity Report and Appendix 4C for Q4 FY2023

Quarterly Activity Report and Appendix 4C for Q3 FY2023

4DMedical Reports 1H FY2023 Results

Appendix 4D and Half-Year Financial Report

Quarterly Activity Report and Appendix 4C for Q2 FY2023

Software Products
  • CAC™
  • CT LVAS™
  • LDAf™
  • LDAi™
  • RV/LV Analysis™
  • XV LVAS®
  • Lung Density Analysis™ – Inspiration
  • Lung Texture Analysis™
  • PHA™
  • IQ-UIP
Hardware Products
  • Permetium™
  • XV Scanner™
  • About
  • Careers
  • Clinical Research
  • Investor
  • News
  • Contact us
  • Intellectual Property
  • Product Regulatory Information
  • Scan Location

Locations

  • Level 7/700 Swanston Street Carlton VIC 3053 Australia +61 03 9545 5940
  • 21255 Burbank Blvd Suite 120Woodland Hills CA 91367 (Toll Free) 1 833 987 2267
  • ©4DMedical 2025
  • Terms of Use
  • Privacy Policy
  • Products
    • CAC™ – Coronary Artery Calcification
    • CT LVAS™ – Lung Ventilation Analysis
    • IQ-UIP™ – Early IPF Detection
    • LDAf™ -Functional Lung Density Analysis
    • LFAi™ – Lung Density Analysis – Inspiration
    • LTA™ – Lung Texture Analysis
    • PHA™ – Pulmonary Hypertension Assessment
    • XV LVAS® – Lung Ventilation Analysis
    • XV Scanner™ – Dedicated Lung Function Scanner
  • Clinical Research
    • Clinical Studies
    • Publications
  • About
    • About Us
    • Our Team
    • ATS
    • Careers
    • Veteran Advocacy
  • Investor Relations
    • Company Information
    • Corporate Governance
    • Results + Reports
    • Share Price and Tools
    • Investor Services
    • Investor Contacts
  • News
    • Latest News
    • Conferences + Events
    • Releases and Archives
    • Blog
  • Contact
    • Contact Us
    • Scan Locations
  • Scan Locations
CUSTOMER SUPPORT